STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
4
13F, latest reported quarter
What the filings say about NYC
Insiders, 180 days
+$239.2K net bought
3 buyers
Planned sales (Form 144), 90 days
$482.5K
4 notices
American Strategic Investment insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, American Strategic Investment Co. insiders bought a net $239.2K of stock across 266 Form 4 purchases and sales, with 3 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
44 earlier Form 4 trades (code P or S) here by this insider (44 buys), the last on Jan 23, 2026.
+8.0% median (+3.9% mean) 90-day return after 30 previous buys.
The trade is 0.7% of the 1,089,620 shares held after it.
2 other insiders bought within 30 days.
4 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider SCHORSCH NICHOLAS S bought about $76.2K of NYC on Jun 30, 2026, the largest insider purchase at the company since 2024; 2 other insiders bought within 30 days and 4 funds added in the latest 13F quarter.
49 earlier Form 4 trades (code P or S) here by this insider (49 buys), the last on Jun 25, 2026.
+13.3% median (+7.8% mean) 90-day return after 30 previous buys.
The trade is 0.5% of the 1,081,620 shares held after it.
2 other insiders bought within 30 days.
4 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider AR Global Investments, LLC bought about $46.4K of NYC on Jun 29, 2026, the largest insider purchase at the company since 2024; 2 other insiders bought within 30 days and 4 funds added in the latest 13F quarter.
48 earlier Form 4 trades (code P or S) here by this insider (48 buys), the last on Nov 24, 2025.
+13.3% median (+7.6% mean) 90-day return after 30 previous buys.
The trade is 0.1% of the 1,076,620 shares held after it.
2 other insiders bought within 30 days.
4 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider AR Global Investments, LLC bought about $8.4K of NYC on Jun 25, 2026; 2 other insiders bought within 30 days and 4 funds added in the latest 13F quarter.
266 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
NYC planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
EDWARD M WEIL JR
Filed 2026-09-14
$160.0K
EDWARD M WEIL JR
Filed 2026-08-28
$135.0K
EDWARD M WEIL JR
Filed 2026-08-24
$120.0K
EDWARD M WEIL JR
Filed 2026-08-13
$67.5K
NYC mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
VANGUARD EXTENDED MARKET INDEX FUND
$174.0K position · as of 2026-06-30
0.0%
Fidelity Extended Market Index Fund
$64.1K position · as of 2026-05-31
0.0%
Fidelity Total Market Index Fund
$51.7K position · as of 2026-05-31
0.0%
Fidelity Series Total Market Index Fund
$23.7K position · as of 2026-05-31
0.0%
VANGUARD TOTAL STOCK MARKET INDEX FUND
$28.2K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
3 insiders reported buying shares.
The record shows a net $239.2K bought by insiders over 180 days, 4 funds added last quarter, $482.5K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Revenue, TTM NYC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM NYC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
-$2.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM NYC
FY Dec 2025
-$8.5M
FY Dec 2024
-$5.3M
FY Dec 2023
-$11.5M
FY Dec 2022
-$6.0M
FY Dec 2021
-$11.3M
Jun 2026
-$45.0K
Mar 2026
-$283.0K
Dec 2025
-$3.0M
Sep 2025
$612.0K
Jun 2025
-$3.0M
Mar 2025
-$3.1M
Dec 2024
-$7.7M
Sep 2024
$2.2M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity NYC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt NYC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+29.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity NYC
FY Dec 2025
-28.2%
FY Dec 2024
-90.6%
FY Dec 2023
-40.3%
FY Dec 2022
-14.3%
FY Dec 2021
-11.0%
Jun 2026
+29.4%
Mar 2026
-30.4%
Dec 2025
-28.2%
Sep 2025
-25.8%
Jun 2025
-112.6%
Mar 2025
-96.2%
Dec 2024
-90.6%
Sep 2024
-106.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets NYC
FY Dec 2025
-4.5%
FY Dec 2024
-23.4%
FY Dec 2023
-14.3%
FY Dec 2022
-5.7%
FY Dec 2021
-4.7%
Jun 2026
+2.9%
Mar 2026
-4.3%
Dec 2025
-4.5%
Sep 2025
-4.2%
Jun 2025
-17.2%
Mar 2025
-23.8%
Dec 2024
-23.4%
Sep 2024
-31.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital NYC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+11.1%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed NYC
FY Dec 2025
+1.2%
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+11.1%
Mar 2026
+2.0%
Dec 2025
+1.2%
Sep 2025
+0.6%
Jun 2025
-16.2%
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
1.21x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing NYC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
1.97x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value NYC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-14.6%
TTM free cash flow over market value at close 2026-10-23
FCF yield NYC
FY Dec 2025
-38.4%
FY Dec 2024
-23.4%
FY Dec 2023
-61.6%
FY Dec 2022
-22.9%
FY Dec 2021
-8.0%
Jun 2026
-9.7%
Mar 2026
-24.8%
Dec 2025
-38.4%
Sep 2025
-49.9%
Jun 2025
-33.4%
Mar 2025
-32.8%
Dec 2024
-23.4%
Sep 2024
-8.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing NYC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
NYC ranks highest on insider conviction (85th percentile) and profitability (84th), and lowest on growth (1st), among Real Estate peers.
Profitability
84
Inputs
Return on equity+29.4% · 94 pct, sector of 230
Return on assets+2.9% · 68 pct, sector of 255
Return on invested capitaltax provision or pre-tax income not filed for the four quarters
Return on capital employed+11.1% · 89 pct, sector of 47
Growth
0
Inputs
Revenue growth, YoY-100.0% · 0 pct, sector of 244
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
85
Inputs
Net Form 4 buying (codes P and S), 180d$239K · 79 pct, sector of 156
Insider buyers, 180d3 · 90 pct, sector of 158
Institutional and government
4
Inputs
Funds adding, latest quarter4 · 4 pct, sector of 171
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
76
Inputs
Short interest, % of float+1.0% · 87 pct, sector of 256
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+6.3% · 64 pct, sector of 212
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
NYC filings, in plain words
Are American Strategic Investment insiders buying or selling NYC?
In the 180 days to 2026-10-28, American Strategic Investment insiders were net buyers, a net $239.2K across purchases and sales reported on Form 4, by 3 buyers.
Are there planned insider sales of NYC?
Yes. 4 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $482.5K of stock; the latest, by EDWARD M WEIL JR, was filed 2026-09-14.
Read the full summary
In the 180 days to 2026-10-28, American Strategic Investment insiders were net buyers of NYC, a net $239.2K across purchases and sales reported on Form 4 by 3 buyers. Most of that figure, $239.2K, came from a holder of 10% or more rather than an officer or director. 3 insiders reported purchases in that window. Insiders filed 4 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $482.5K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.